A new scheduling system significantly reduces waiting times for surgeries, enhancing efficiency and patient care. ORCAL cut average waiting times by 7.5 days overall, with grade 1 cases seeing a reduction of 12.3 days. Total operative days dropped from 521 to 417, while surgical time per day increased from 462.4 to 488.1 minutes. This means […]
Author: STITCHES Newsletter
Refined Risk Stratification in Cholangiocarcinoma Resection
Anatomic and biologic criteria improve recurrence predictions post-surgery for perihilar cholangiocarcinoma, enhancing patient selection. Anatomic borderline resectability alone failed to predict recurrence; adding CA19-9 biomarker separated patients into three distinct risk levels for recurrence-free survival. Two-year recurrence-free survival rates were 55.7%, 37.8%, and 25.3% for low-, intermediate-, and high-risk groups respectively. This approach shifts decision-making […]
Bevacizumab strategies enhance surgical options in liver metastases
Patients with initially unresectable colorectal liver metastases benefit from certain induction therapies that increase surgical conversion potential. Bevacizumab plus triplet chemotherapy showed a 99% probability of improving R0-1 resection rates and progression-free survival. Bevacizumab plus doublet chemotherapy offers a more balanced benefit-risk profile, favoring safer patient outcomes. Consider adjusting induction regimens based on genetic tumor […]
Laparoscopic Surgery is Non-Inferior for Stage IV Colon Cancer
Laparoscopic surgery offers similar outcomes to open surgery for non-curable stage IV colon cancer. Three-year progression-free survival: 5.3% for open vs. 3.0% for laparoscopic (hazard ratio 1.028). Three-year overall survival: 31.5% for open vs. 28.5% for laparoscopic (hazard ratio 1.048). Laparoscopic approaches may improve recovery and reduce hospital stays without compromising survival. Grade ≥3 late […]
Robotic Single-Port Hartmann Reversal is Safe and Effective
A robotic single-port approach for Hartmann reversal enhances surgical feasibility while minimizing trauma. Five patients underwent the procedure with no major complications. Mean operating time was 199 minutes, and hospital stay averaged 4 days. This technique leverages robotic instrumentation to reduce tissue damage and the risk of enteric injury, making it a strong option for […]
Molecular insights reshape cholangiocarcinoma surgery.
Cholangiocarcinomas show significant biological diversity, influencing treatment and patient selection. High rates of actionable mutations in intrahepatic cholangiocarcinoma, such as FGFR2 fusions and IDH1/2 mutations, offer new therapeutic targets. Understanding the molecular subtypes can enhance surgical approaches and refine prognostic assessments. Tailoring surgical strategies based on molecular profiles can improve outcomes in cholangiocarcinoma patients. Review […]
Robotic Cholecystectomy Cuts Complications in Complex Cases
Robotic-assisted cholecystectomy significantly reduces the need for unplanned procedures in complex gallbladder surgeries. Patients undergoing robotic cholecystectomy had a 4.24 odds ratio for fewer interventions compared to laparoscopic techniques (p = .02). Operating room costs are higher for robotics: $8,936 vs. $7,720 for laparoscopic in complex cases. Robotic cholecystectomy maintains overall care costs similar to […]
Survival Advantage in Esophageal Cancer: FLOT vs CROSS
Patients with esophageal adenocarcinoma achieving pathological complete response show better outcomes with FLOT chemotherapy compared to CROSS chemoradiotherapy. FLOT patients had a significantly lower recurrence rate (8.8%) vs. CROSS (24.7%). Overall survival was much better in the FLOT group, with a hazard ratio of 0.34 after adjustment. Surgeons should consider FLOT for better long-term survival […]
Palliative Care’s Impact on End-of-Life Procedures in HPB Cancer
Incorporating palliative care can significantly impact procedural decisions for patients with hepatopancreatobiliary cancers. Among 2,848 patients, 48.2% underwent inpatient procedures; 40.7% received palliative care. Early palliative care involvement correlated with a 29% lower chance of undergoing nonpalliative procedures (odds ratio 0.71). Greater integration of palliative care may enhance decision-making aligned with patient quality of life […]
Mesoglycan Effective for Acute Hemorrhoidal Disease Relief
Mesoglycan significantly improves symptoms in acute hemorrhoidal disease management, enhancing surgical outcomes. Patients taking mesoglycan saw a symptom score reduction of -7.5 vs -3.9 for placebo (p = .027). Significant symptom relief was noted, especially in grade III patients with reduced itching (p = .0048), pain (p = .0246), and swelling/prolapse (p = .0418). This […]